1. Gaus O. V., Livzan M. A. SRK: Chto mi znaem o simptomah segodnya [IBS: what do we know about the symptoms to day?]. Consilium Medicum. 2019, vol. 21, no. 8, pp. 42–48. (in Russ.)
2. Livzan M.A., Osipenko M. F. Sindrom perecresta functcional’nih zabolevanii pishevaritel’nogo tracta [Overlapsyndrome of functional diseases of the digestive tract.]. RMJ. 2012, vol. 20, no. 15, pp. 768–770. (in Russ.)
3. Ivashkin V.T., Shelygin Yu.A., Baranskaya E. K. et al. Klinicheskiye recommendacii Rossiiskoy gastroenterologicheskoi assotciatcii, Assotciatcii coloproctologov Rossii po diagnostike i lecheniyu bol’nih s sindromom razdrazhennogo kishechnika [Clinical recommendations of the Russian Gastroenterological Association, the Association of Coloproctologists of Russia on the diagnosis and treatment of patients with irritable bowel syndrome]. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproctologii – Russian Journal of Gastroenterology of Hepatology Coloproctology. 2017, vol. 27, no. 5, pp. 76–93. (in Russ.)
4. Vakil N., Stelwagon M., Shea E. P., Miller S. Symptom burden and consulting behavior in patients with overlapping functional disorders in the US population. United European Gastroenterol. J. 2015, vol. 4, no. 3, pp. 413–422.
5. Häuser W., Marschall U., Layer P., Grobe T. The prevalence, comorbidity, management and costs of irritable bowel syndrome – an observational study using routine health insurance data. Dtsch. Arztebl. Int. 2019, no. 116, pp. 463–470.